These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19047650)

  • 1. Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection.
    Thakkar N; Pirrone V; Passic S; Zhu W; Kholodovych V; Welsh W; Rando RF; Labib ME; Wigdahl B; Krebs FC
    Antimicrob Agents Chemother; 2009 Feb; 53(2):631-8. PubMed ID: 19047650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection.
    Thakkar N; Pirrone V; Passic S; Keogan S; Zhu W; Kholodovych V; Welsh W; Rando R; Labib M; Wigdahl B; Krebs FC
    Antimicrob Agents Chemother; 2010 May; 54(5):1965-72. PubMed ID: 20231400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine model.
    Lozenski K; Kish-Catalone T; Pirrone V; Rando RF; Labib M; Wigdahl B; Krebs FC
    J Biomed Biotechnol; 2011; 2011():941061. PubMed ID: 22131821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1.
    Passic SR; Ferguson ML; Catalone BJ; Kish-Catalone T; Kholodovych V; Zhu W; Welsh W; Rando R; Howett MK; Wigdahl B; Labib M; Krebs FC
    Biomed Pharmacother; 2010 Dec; 64(10):723-32. PubMed ID: 21106331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.
    Klasse PJ; Rosenkilde MM; Signoret N; Pelchen-Matthews A; Schwartz TW; Marsh M
    J Virol; 1999 Sep; 73(9):7453-66. PubMed ID: 10438835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
    Schols D; Esté JA; Cabrera C; De Clercq E
    J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.
    Murakami T; Zhang TY; Koyanagi Y; Tanaka Y; Kim J; Suzuki Y; Minoguchi S; Tamamura H; Waki M; Matsumoto A; Fujii N; Shida H; Hoxie JA; Peiper SC; Yamamoto N
    J Virol; 1999 Sep; 73(9):7489-96. PubMed ID: 10438838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plectin regulates the signaling and trafficking of the HIV-1 co-receptor CXCR4 and plays a role in HIV-1 infection.
    Ding Y; Zhang L; Goodwin JS; Wang Z; Liu B; Zhang J; Fan GH
    Exp Cell Res; 2008 Feb; 314(3):590-602. PubMed ID: 18155192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive and persistent downregulation of surface CXCR4 in CD4(+) T cells infected with human herpesvirus 7.
    Secchiero P; Zella D; Barabitskaja O; Reitz MS; Capitani S; Gallo RC; Zauli G
    Blood; 1998 Dec; 92(12):4521-8. PubMed ID: 9845516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
    Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
    Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection.
    Cabrera C; Gutiérrez A; Blanco J; Barretina J; Litovchick A; Lapidot A; Evdokimov AG; Clotet B; Esté JA
    AIDS Res Hum Retroviruses; 2000 May; 16(7):627-34. PubMed ID: 10791873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4.
    Misumi S; Takamune N; Ido Y; Hayashi S; Endo M; Mukai R; Tachibana K; Umeda M; Shoji S
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1309-16. PubMed ID: 11478800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection.
    Chevigné A; Fievez V; Szpakowska M; Fischer A; Counson M; Plesséria JM; Schmit JC; Deroo S
    Biochim Biophys Acta; 2014 May; 1843(5):1031-41. PubMed ID: 24480462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
    Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
    J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1.
    Krebs FC; Miller SR; Ferguson ML; Labib M; Rando RF; Wigdahl B
    Biomed Pharmacother; 2005 Sep; 59(8):438-45. PubMed ID: 16154720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection.
    Patrussi L; Baldari CT
    Curr Med Chem; 2011; 18(4):497-512. PubMed ID: 21143114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of HIV-1 evasion to the antiviral activity of chemokine CXCL12 indicate potential links with pathogenesis.
    Armani-Tourret M; Zhou Z; Gasser R; Staropoli I; Cantaloube-Ferrieu V; Benureau Y; Garcia-Perez J; Pérez-Olmeda M; Lorin V; Puissant-Lubrano B; Assoumou L; Delaugerre C; Lelièvre JD; Lévy Y; Mouquet H; Martin-Blondel G; Alcami J; Arenzana-Seisdedos F; Izopet J; Colin P; Lagane B
    PLoS Pathog; 2021 Apr; 17(4):e1009526. PubMed ID: 33872329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXC-chemokine receptor 4 is not a coreceptor for human herpesvirus 7 entry into CD4(+) T cells.
    Zhang Y; Hatse S; De Clercq E; Schols D
    J Virol; 2000 Feb; 74(4):2011-6. PubMed ID: 10644374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor.
    Fenard D; Lambeau G; Maurin T; Lefebvre JC; Doglio A
    Mol Pharmacol; 2001 Aug; 60(2):341-7. PubMed ID: 11455021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.